中国癌症杂志 ›› 2014, Vol. 24 ›› Issue (10): 721-726.doi: 10.3969/j.issn.1007-3969.2014.10.001

• 专家述评 • 上一篇    下一篇

淋巴瘤病理研究新进展

李小秋   

  1. 复旦大学附属肿瘤医院病理科,复旦大学上海医学院肿瘤学系,上海200032
  • 出版日期:2014-10-30 发布日期:2014-11-12
  • 通信作者: 李小秋 E-mail:leexiaoqiu@hotmail.com
  • 作者简介:李小秋,主任医师、硕士生导师。现任复旦大学附属肿瘤医院病理科淋巴造血病理专科负责人。兼任中国抗癌协会淋巴瘤专业委员会常务委员暨病理学组副组长、中国抗癌协会淋巴瘤专业委员会青年学术委员会副主任委员、中华医学会病理学分会淋巴造血系统学组副组长、CSCO抗淋巴瘤联盟常务委员、中国抗癌协会血液肿瘤专业委员会血液病理工作组委员,中国抗癌协会肿瘤病理专业委员会青年委员、上海市抗癌协会淋巴瘤专业委员会副主任委员。现任《中华临床医师杂志》学术委员会委员、《诊断病理学杂志》、《白血病?淋巴瘤》编委、《中华病理学杂志》、《中国肿瘤临床》和《临床与实验病理学杂志》特邀审稿专家。现主要从事肿瘤病理诊断和研究工作,尤其擅长淋巴造血组织疾病病理,对于疑难病例和罕见病种的诊断和鉴别积累了丰富的经验。当前主要研究方向为弥漫性大B细胞淋巴瘤中B细胞受体信号途径以及MYC基因异常的调节机制及临床意义。曾负责或参与卫生部临床学科重点项目、国家自然科学基金、上海市科委基金资助的科研项目。迄今发表学术论文61篇(SCI论文20篇)。

New advances in lymphoma pathology

LI Xiao-qiu   

  1. Department of Pathology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China
  • Published:2014-10-30 Online:2014-11-12
  • Contact: LI Xiao-qiu E-mail: leexiaoqiu@hotmail.com

摘要:

2008年版WHO淋巴瘤分类出版以来的数年中,淋巴瘤病理相关的知识又有所更新。对于B细胞非霍奇金淋巴瘤,人们较关注那些高度侵袭而又异质的亚型(例如:弥漫性大B细胞淋巴瘤),并努力尝试在分子生物学基础之上建立起更好的分型方法。此外,人们对于如何正确理解并处理明显的恶性淋巴瘤以及那些并不具有明确恶性行为、克隆性淋巴组织增生性疾病之间的“边界性”病变的兴趣也日益增长。另一方面,有关TNK(T/NK)细胞的亚群构成、细胞分化方面的研究进展以及新近认识到的外周T/NK细胞淋巴瘤中的遗传学异常和信号路径调节失常,也有助于我们更深入地了解这些肿瘤的生物学特性。临床惰性、克隆性T/NK细胞增生性病变、特别是发生于黏膜皮肤部位者,也愈发受到人们关注。这些新的知识进展会推动淋巴瘤分类不断向前演进

关键词: 进展, 淋巴瘤, B细胞, T和NK细胞, 分类, 侵袭性, 惰性克隆性淋巴组织增生性疾病

Abstract:

Updated knowledge about lymphoma pathology has been accumulated ever since the publication of the current WHO classification of lymphomas in 2008. For B-cell non-Hodgkin lymphomas, endeavors have been made for approaching a better classification of those highly aggressive and heterogeneous subtypes (e.g., diffuse large B-cell lymphomas) on the molecular biological basis. In addition, there is a growing interest in understanding and dealing with the borders of overt malignant lymphomas and certain clonal lymphproliferative disorders that are not overtly malignant. On the other hand, recent advances in understanding the subsets of T and NK (T/NK)-cell lineage and their differentiation, as well as the genetic aberrations or dysregulated signaling pathways in their neoplastic counterparts, have provided us novel insights into the biology of peripheral T/NK-cell lymphomas. Indolent clonal T/NK-cell proliferations, especially those arising from the mucocutaneous sites, have also received increased attention. These advances may contribute to the evolution of the classification of lymphomas.

Key words: Advances, Lymphoma, B-cell, T and NK-cell, Classification, Aggressive, Indolent clonal lymphoproliferative disorders